HomeCompareVTEPF vs MRK

VTEPF vs MRK: Dividend Comparison 2026

VTEPF yields 6309.15% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VTEPF wins by $1731.48M in total portfolio value
10 years
VTEPF
VTEPF
● Live price
6309.15%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1731.53M
Annual income
$52,585,993.37
Full VTEPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VTEPF vs MRK

📍 VTEPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVTEPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VTEPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VTEPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VTEPF
Annual income on $10K today (after 15% tax)
$536,277.60/yr
After 10yr DRIP, annual income (after tax)
$44,698,094.36/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, VTEPF beats the other by $44,689,765.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VTEPF + MRK for your $10,000?

VTEPF: 50%MRK: 50%
100% MRK50/50100% VTEPF
Portfolio after 10yr
$865.80M
Annual income
$26,297,895.76/yr
Blended yield
3.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VTEPF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.7
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VTEPF buys
0
MRK buys
0
No recent congressional trades found for VTEPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVTEPFMRK
Forward yield6309.15%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$1731.53M$56.8K
Annual income after 10y$52,585,993.37$9,798.13
Total dividends collected$1343.33M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: VTEPF vs MRK ($10,000, DRIP)

YearVTEPF PortfolioVTEPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$326,157$315,457.41$11,206$366.19+$315.0KVTEPF
2$5,156,875$4,807,886.63$12,650$502.35+$5.14MVTEPF
3$41,040,052$35,522,195.56$14,407$694.19+$41.03MVTEPF
4$176,014,225$132,101,369.14$16,585$967.82+$176.00MVTEPF
5$453,083,661$264,748,440.92$19,342$1,363.89+$453.06MVTEPF
6$803,256,131$318,456,613.41$22,913$1,947.19+$803.23MVTEPF
7$1,123,306,752$263,822,691.55$27,662$2,823.89+$1123.28MVTEPF
8$1,374,340,381$172,402,156.37$34,159$4,173.35+$1374.31MVTEPF
9$1,569,109,691$98,565,483.82$43,337$6,308.80+$1569.07MVTEPF
10$1,731,533,363$52,585,993.37$56,776$9,798.13+$1731.48MVTEPF

VTEPF vs MRK: Complete Analysis 2026

VTEPFStock

Videndum Plc designs, manufactures, and distributes products and services that enable end users to capture and share exceptional content for the broadcast, cinematic, video, photographic, and smartphone applications worldwide. It operates through three divisions: Imaging Solutions, Production Solutions, and Creative Solutions. The Imaging Solutions division offers equipment for photographic and video cameras, and smartphones; and solutions to professional and amateur photographers/videographers, independent content creators (ICCs), vloggers/influencers, gamers, enterprises, and professional sound crews comprising camera supports and heads, smartphone accessories, lighting supports, light-emitting diode (LED) lighting, lighting controls, motion controls, audio capture and noise reduction equipment, and camera bags and backgrounds. The Production Solutions division provides video heads, tripods, LED lighting, prompters, robotic camera systems, and mobile power solutions, as well as equipment rental and technical solutions for broadcasters, film and video production companies, ICCs, and enterprises. The Creative Solutions division offers wireless video transmission and lens control systems, monitors, camera accessories, live streaming and IP video devices, and software applications to ICCs, enterprises, gamers, broadcasters, and film and video production companies. The company was formerly known as The Vitec Group plc and changed its name to Videndum Plc in May 2022. Videndum Plc was founded in 1909 and is headquartered in Richmond, the United Kingdom.

Full VTEPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VTEPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VTEPF vs SCHDVTEPF vs JEPIVTEPF vs OVTEPF vs KOVTEPF vs MAINVTEPF vs JNJVTEPF vs ABBVVTEPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.